RUNX2 mutations in cleidocranial dysplasia patients.

Article Details

Citation

Ryoo HM, Kang HY, Lee SK, Lee KE, Kim JW

RUNX2 mutations in cleidocranial dysplasia patients.

Oral Dis. 2010 Jan;16(1):55-60. doi: 10.1111/j.1601-0825.2009.01623.x. Epub 2009 Sep 8.

PubMed ID
19744171 [ View in PubMed
]
Abstract

OBJECTIVE: Mutations in the RUNX2 gene, a master regulator of bone formation, have been identified in cleidocranial dysplasia (CCD) patients. CCD is a rare autosomal-dominant disease characterized by the delayed closure of cranial sutures, defects in clavicle formation, and supernumerary teeth. The purposes of this study were to identify genetic causes of two CCD nuclear families and to report their clinical phenotypes. MATERIALS AND METHODS: We identified two CCD nuclear families and performed mutational analyses to clarify the underlying molecular genetic etiology. RESULTS: Mutational analysis revealed a novel nonsense mutation (c.273T>A, p.L93X) in family 1 and a de novo missense one (c.673C>T, p.R225W) in family 2. Individuals with a nonsense mutation showed maxillary hypoplasia, delayed eruption, multiple supernumerary teeth, and normal stature. In contrast, an individual with a de novo missense mutation in the Runt domain showed only one supernumerary tooth and short stature. CONCLUSIONS: Mutational and phenotypic analyses showed that the severity of mutations on the skeletal system may not necessarily correlate with that of the disruption of tooth development.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
Runt-related transcription factor 2Q13950Details